Development of a rapid Focus Reduction Neutralization Test Assay for measuring SARS-CoV-2 neutralizing antibodies

SARS-CoV-2 is a recently emerged human coronavirus that escalated to a pandemic. There are currently no approved vaccines for SARS-CoV-2, which causes severe respiratory illness or death. Defining the antibody response to SARS-CoV-2 will be essential for understanding disease progression, long-term...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Protoc Immunol
Autori principali: Vanderheiden, Abigail, Edara, Venkata Viswanadh, Floyd, Katharine, Kauffman, Robert C., Mantus, Grace, Anderson, Evan, Rouphael, Nadine, Edupuganti, Sri, Shi, Pei-Yong, Menachery, Vineet D., Wrammert, Jens, Suthar, Mehul S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864545/
https://ncbi.nlm.nih.gov/pubmed/33215858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpim.116
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi